| Plague vaccine: recent progress and prospects W Sun, AK Singh npj Vaccines 4 (1), 11, 2019 | 80 | 2019 |
| Highly Efficient Method for Introducing Successive Multiple Scarless Gene Deletions and Markerless Gene Insertions into the Yersinia pestis Chromosome W Sun, S Wang, R Curtiss III Applied and environmental microbiology 74 (13), 4241-4245, 2008 | 77 | 2008 |
| Live Recombinant Salmonella Typhi Vaccines Constructed to Investigate the Role of rpoS in Eliciting Immunity to a Heterologous Antigen H Shi, J Santander, KE Brenneman, SY Wanda, S Wang, P Senechal, ... PloS one 5 (6), e11142, 2010 | 60 | 2010 |
| The role of relA and spoT in Yersinia pestis KIM5+ pathogenicity W Sun, KL Roland, CG Branger, X Kuang, R Curtiss III PloS one 4 (8), e6720, 2009 | 59 | 2009 |
| Comparison of a Regulated Delayed Antigen Synthesis System with In Vivo-Inducible Promoters for Antigen Delivery by Live Attenuated Salmonella Vaccines S Wang, Y Li, H Shi, W Sun, KL Roland, R Curtiss III Infection and immunity 79 (2), 937-949, 2011 | 53 | 2011 |
| A live attenuated strain of Yersinia pestis KIM as a vaccine against plague W Sun, D Six, X Kuang, KL Roland, CRH Raetz, R Curtiss III Vaccine 29 (16), 2986-2998, 2011 | 52 | 2011 |
| Developing live vaccines against plague W Sun, KL Roland, R Curtiss III The Journal of Infection in Developing Countries 5 (09), 614-627, 2011 | 49 | 2011 |
| Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge CG Branger, W Sun, A Torres-Escobar, R Perry, KL Roland, J Fetherston, ... Vaccine 29 (2), 274-282, 2010 | 48 | 2010 |
| A Schistosoma japonicumchimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens X Xu, D Zhang, W Sun, Q Zhang, J Zhang, X Xue, L Shen, W Pan BMC Infectious Diseases 9, 1-14, 2009 | 42 | 2009 |
| Yersinia pestis with Regulated Delayed Attenuation as a Vaccine Candidate To Induce Protective Immunity against Plague W Sun, KL Roland, X Kuang, CG Branger, R Curtiss III Infection and immunity 78 (3), 1304-1313, 2010 | 37 | 2010 |
| Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonellaenterica serovar Typhimurium elicits a protective immune response against challenge … CG Branger, A Torres-Escobar, W Sun, R Perry, J Fetherston, KL Roland, ... Vaccine 27 (39), 5363-5370, 2009 | 37 | 2009 |
| Microbial Colonization Coordinates the Pathogenesis of a Klebsiella pneumoniae Infant Isolate JL Pope, Y Yang, RC Newsome, W Sun, X Sun, M Ukhanova, J Neu, ... Scientific Reports 9 (1), 3380, 2019 | 36 | 2019 |
| Mucosal-associated invariant T cells restrict reactive oxidative damage and preserve meningeal barrier integrity and cognitive function Y Zhang, JT Bailey, E Xu, K Singh, M Lavaert, VM Link, S D’Souza, ... Nature immunology 23 (12), 1714-1725, 2022 | 34 | 2022 |
| Induction of protective antiplague immune responses by self-adjuvanting bionanoparticles derived from engineered Yersinia pestis X Wang, AK Singh, X Zhang, W Sun Infection and immunity 88 (5), 10.1128/iai. 00081-20, 2020 | 31 | 2020 |
| Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague S Sanapala, H Rahav, H Patel, W Sun, R Curtiss Vaccine 34 (21), 2410-2416, 2016 | 25 | 2016 |
| LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague W Sun, S Sanapala, JC Henderson, S Sam, J Olinzock, MS Trent, ... Infection and immunity 82 (10), 4390-4404, 2014 | 25 | 2014 |
| Plague vaccines: status and future W Sun Yersinia pestis: Retrospective and Perspective, 313-360, 2016 | 23 | 2016 |
| Blockade of IL-4Rα inhibits group 2 innate lymphoid cell responses in asthma patients G Patel, J Pan, L Ye, X Shen, D Rosloff, SS D’Souza, ITH Fung, J Celstin, ... Clinical and experimental allergy: journal of the British Society for …, 2020 | 21 | 2020 |
| Rational considerations about development of live attenuated Yersinia pestis vaccines W Sun, R Curtiss Current pharmaceutical biotechnology 14 (10), 878-886, 2013 | 21 | 2013 |
| Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A W Sun, DA Six, CM Reynolds, HS Chung, CRH Raetz, R Curtiss 3rd Infection and immunity 81 (4), 1172-1185, 2013 | 20 | 2013 |
